Update on treatment of light chain amyloidosis | Haematologica
Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease [PeerJ]
Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation | Biochemistry
Measurement of kappa (κ) and lambda (λ) light chains in free and total... | Download Scientific Diagram
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire
Frontiers | Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire
Frontiers | Comparative Aspects of Immunoglobulin Gene Rearrangement Arrays in Different Species
Immunoglobulin Light Chain Kappa/Lambda Detection
Amyloid formation by antibody light chains. In AL amyloidosis, LCs,... | Download Scientific Diagram
Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications | Experimental Hematology & Oncology | Full Text
The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation | Modern Pathology
Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease
In-depth determination and analysis of the human paired heavy- and light- chain antibody repertoire | Nature Medicine
Crystal structure of 6aJL2-R24G light chain variable domain: Does crystal packing explain amyloid fibril formation? - ScienceDirect
Figure A. Center: Structure of a typical immunoglobulin (antibody)... | Download Scientific Diagram
Light chain modulates heavy chain conformation to change protection profile of monoclonal antibodies against influenza A viruses | Cell Discovery
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis